174 related articles for article (PubMed ID: 9346882)
1. Atypical protein kinase C iota protects human leukemia cells against drug-induced apoptosis.
Murray NR; Fields AP
J Biol Chem; 1997 Oct; 272(44):27521-4. PubMed ID: 9346882
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C isotypes in human erythroleukemia (K562) cell proliferation and differentiation. Evidence that beta II protein kinase C is required for proliferation.
Murray NR; Baumgardner GP; Burns DJ; Fields AP
J Biol Chem; 1993 Jul; 268(21):15847-53. PubMed ID: 8340409
[TBL] [Abstract][Full Text] [Related]
3. NF-kappaB/RelA transactivation is required for atypical protein kinase C iota-mediated cell survival.
Lu Y; Jamieson L; Brasier AR; Fields AP
Oncogene; 2001 Aug; 20(35):4777-92. PubMed ID: 11521190
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C chimeras: catalytic domains of alpha and beta II protein kinase C contain determinants for isotype-specific function.
Walker SD; Murray NR; Burns DJ; Fields AP
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9156-60. PubMed ID: 7568092
[TBL] [Abstract][Full Text] [Related]
5. Decursin and PDBu: two PKC activators distinctively acting in the megakaryocytic differentiation of K562 human erythroleukemia cells.
Kim HH; Ahn KS; Han H; Choung SY; Choi SY; Kim IH
Leuk Res; 2005 Dec; 29(12):1407-13. PubMed ID: 15992925
[TBL] [Abstract][Full Text] [Related]
6. Phorbol 12-myristate 13-acetate induces protein kinase ceta-specific proliferative response in astrocytic tumor cells.
Hussaini IM; Karns LR; Vinton G; Carpenter JE; Redpath GT; Sando JJ; VandenBerg SR
J Biol Chem; 2000 Jul; 275(29):22348-54. PubMed ID: 10806212
[TBL] [Abstract][Full Text] [Related]
7. Human leukemia K562 cell mutant (K562/OA200) selected for resistance to okadaic acid (protein phosphatase inhibitor) lacks protein kinase C-epsilon, exhibits multidrug resistance phenotype, and expresses drug pump P-glycoprotein.
Zheng B; Chambers TC; Raynor RL; Markham PN; Gebel HM; Vogler WR; Kuo JF
J Biol Chem; 1994 Apr; 269(16):12332-8. PubMed ID: 7512966
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C isotypes in human erythroleukemia cell proliferation and differentiation.
Hocevar BA; Morrow DM; Tykocinski ML; Fields AP
J Cell Sci; 1992 Mar; 101 ( Pt 3)():671-9. PubMed ID: 1522149
[TBL] [Abstract][Full Text] [Related]
9. Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells.
Powell CT; Brittis NJ; Stec D; Hug H; Heston WD; Fair WR
Cell Growth Differ; 1996 Apr; 7(4):419-28. PubMed ID: 9052983
[TBL] [Abstract][Full Text] [Related]
10. A novel PKC-ι inhibitor abrogates cell proliferation and induces apoptosis in neuroblastoma.
Pillai P; Desai S; Patel R; Sajan M; Farese R; Ostrov D; Acevedo-Duncan M
Int J Biochem Cell Biol; 2011 May; 43(5):784-94. PubMed ID: 21315177
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of phorbol ester on growth and protein kinase C isoenzyme regulation in human hepatoma Hep3B cells.
Hsu SL; Chou YH; Yin SC; Liu JY
Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):57-64. PubMed ID: 9639562
[TBL] [Abstract][Full Text] [Related]
12. The effects of the broadband UVA radiation on myeloid leukemia cells: the possible role of protein kinase C in mediation of UVA-induced effects.
Leszczynski D; Fagerholm S; Leszczynski K
Photochem Photobiol; 1996 Dec; 64(6):936-42. PubMed ID: 8972634
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of protein kinase C-beta1 isoenzyme suppresses indomethacin-induced apoptosis in gastric epithelial cells.
Zhu GH; Wong BC; Slosberg ED; Eggo MC; Ching CK; Yuen ST; Lai KC; Soh JW; Weinstein IB; Lam SK
Gastroenterology; 2000 Mar; 118(3):507-14. PubMed ID: 10702201
[TBL] [Abstract][Full Text] [Related]
14. Mapping of a molecular determinant for protein kinase C betaII isozyme function.
Gökmen-Polar Y; Fields AP
J Biol Chem; 1998 Aug; 273(32):20261-6. PubMed ID: 9685375
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
Arita Y; Buffolino P; Coppock DL
Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of protein kinase C isozymes and erythroleukemia cell differentiation.
Melloni E; Pontremoli S; Viotti PL; Patrone M; Marks PA; Rifkind RA
J Biol Chem; 1989 Nov; 264(31):18414-8. PubMed ID: 2808382
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C iota mediates lipid-induced apoptosis of human coronary artery endothelial cells.
Staiger K; Schatz U; Staiger H; Weyrich P; Haas C; Guirguis A; Machicao F; Häring HU; Kellerer M
Microvasc Res; 2009 Jun; 78(1):40-4. PubMed ID: 19327373
[TBL] [Abstract][Full Text] [Related]
18. Involvement of PKC and ROS in the cytotoxic mechanism of anti-leukemic decursin and its derivatives and their structure-activity relationship in human K562 erythroleukemia and U937 myeloleukemia cells.
Kim HH; Sik Bang S; Seok Choi J; Han H; Kim IH
Cancer Lett; 2005 Jun; 223(2):191-201. PubMed ID: 15896453
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and characterization of PKC iota, an atypical isoform of protein kinase C derived from insulin-secreting cells.
Selbie LA; Schmitz-Peiffer C; Sheng Y; Biden TJ
J Biol Chem; 1993 Nov; 268(32):24296-302. PubMed ID: 8226978
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C epsilon translocation and phosphorylation by cis-diamminedichloroplatinum(II) (CDDP): potential role in CDDP-mediated cytotoxicity.
Ohmori T; Arteaga CL
Cell Growth Differ; 1998 Apr; 9(4):345-53. PubMed ID: 9563854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
